Onconetix earnings were -$45.9M for the trailing 12 months ending Jun 30, 2025, with N/A growth year over year. The latest ONCO earnings report on Jun 30, 2025 announced Q2 2025 earnings of -$2.7M, down 72.2% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, ONCO reported annual earnings of -$58.9M, with 57.4% growth. The next ONCO earnings date is Nov 13, 2025.
On ONCO's earnings call on Invalid Date, Onconetix (NASDAQ: ONCO) reported Q2 2025 earnings per share (EPS) of -$4.76, up 99.78% year over year. Total ONCO earnings for the quarter were -$2.70 million. In the same quarter last year, Onconetix's earnings per share (EPS) was -$2,191.59.
The next ONCO earnings call is Invalid Date. Add ONCO to your watchlist to be reminded of Onconetix's next earnings date.
Is Onconetix profitable or losing money?
As of the last Onconetix earnings report, Onconetix is currently losing money. Onconetix's net profit (also called net income) for the twelve months ending Jun 30, 2025 was -$44.18 million, a 16.83% decrease year over year.
What was ONCO's earnings growth in the past year?
As of Onconetix's earnings date in Invalid Date, Onconetix's earnings has grown year over year. ONCO earnings in the past year totalled -$45.89 million.
What are Onconetix's earnings expectations?
The current EPS estimate for Onconetix's earnings report in Invalid Date is $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.